[1] Delgado-LóPez P D, Corrales-GarcíA E M, Martino J, et al. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies [J]. Clin Transl Oncol,2017, 19(8): 1-14.
[2] 陈万青, 郑荣寿, 张思维, 等. 2013年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2017, 26(1): 1-7.
[3] Park J E, Kim H S, Park K J, et al. Pre- and posttreatment glioma: comparison of amide proton transfer imaging with MR spectroscopy for biomarkers of tumor proliferation [J]. Radiology, 2015, 278(2): 142979.
[4] Jiang T, Mao Y, Ma W, et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas [J]. Cancer Lett, 2016, 375(2): 263-273.
[5] Zhu H F, Zhang Y X, Zhao X D. Animal models of human glioma: the progress of application and investigation[J]. Dongwuxue Yanjiu, 2012, 33(3): 337-342.
[6] Ismail F S, Moinfar Z, Prochnow N, et al. Dexamethasone and levetiracetam reduce hetero-cellular gap-junctional coupling between F98 glioma cells and glial cells in vitro [J]. J Neurooncol, 2017, 131(3): 469-476.
[7] Han X, Li H, Zhang Y, et al. Brain lipid-binding protein promotes proliferation and modulates cell cycle in C6 rat glioma cells [J]. Int J Oncol,2017,51(5):1439-1448.
[8] Connolly N P, Stokum J A, Schneider C S, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer [J]. PLoS One, 2017, 12(3): e0174557.
[9] Tian J, Ling Q I, Pengyan J I, et al. Induction effect of NPPB on apoptosis of human glioma SHG-44 cells and its mechanism [J]. J Jilin Uni, 2016, 42(4): 637-641.
[10] Shchelkunov S N, Razumov I A, Kolosova I V, et al. Virotherapy of the malignant U87 human glioblastoma in the orthotopic xenotransplantation mouse SCID model [J]. Dokl Biochem Biophys, 2018, 478(1): 30-33.
[11] He Y N, Zhang S C, Zhang H M. Pathologic changes of spontaneous tumors in Sprague-Dawley and Wistar rats[J]. Zhonghua Bing Li Xue Za Zhi, 2017, 46(4): 249-254.
[12] Biasibetti E, Valazza A, Capucchio M T, et al. Comparison of allogeneic and syngeneic rat glioma models by using MRI and histopathologic evaluation [J]. Comp Med, 2017, 67(2): 147-156.
[13] Coutinho D P, Smith N, Atolagbe O, et al. OKN-007 decreases free radical levels in a preclinical F98 rat glioma model [J]. Free Radic Biol Med, 2015, 87:157-168.
[14] Desmarais G, Charest G, Therriault H, et al. Infiltration of F98 glioma cells in Fischer rat brain is temporary stimulated by radiation [J]. Int J Radiat Biol, 2016, 92(8): 444-450.
[15] 肖宗宇, 陈晓娟, 徐如祥. 9L/F344大鼠脑肿瘤干细胞颅内肿瘤模型的建立 [J]. 中国现代神经疾病杂志, 2015, 15(4): 316-321.
[16] Nagaraja T N, Elmghirbi R, Brown S L, et al. Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model [J]. Magn Reson Imaging, 2017, 44:131-139.
[17] 王 凤, 关丽明. 9L脑胶质瘤干细胞模型建立及MRI成像表现[J]. 现代肿瘤医学, 2016, 24(18): 2835-2838.
[18] Pei J, Park I H, Ryu H H, et al. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model [J]. Radiat Oncol, 2015, 10(1): 1-11.
[19] 王艳华, 楚建杰, 李子敏,等.人U87-MG脑胶质瘤细胞裸鼠原位移植模型的建立[J]. 中国药理学通报, 2018, 34(5): 735-739.
[20] 李英夫, 李明军, 廉晓宇, 等. Wistar大鼠SHG-44脑胶质瘤动物模型建立 [J]. 黑龙江医药科学, 2015, 38(2): 24-25.
[21] Liu W J, Yin Y B, Sun J Y, et al. Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage [J]. Onco Targets Ther, 2018, 11:5429-5439.
[22] Shen Z G, Liu X Z, Chen C X, et al. Knockdown of E2F3 inhibits proliferation, migration, and invasion, and Increases apoptosis in glioma cells [J]. Oncol Res, 2017, 25(9): 1555-1566.
[23] Leten C, Trekker J, Struys T, et al. Monitoring the bystander killing effect of human multipotent stem cells for treatment of malignant brain tumors [J]. Stem Cells Int, 2016, 2016(10): 4095072.
[24] Parrish K E, Pokorny J, Mittapalli R K, et al. Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor model [J]. J Pharmacol Exp Ther, 2015, 355(2): 264-271.
[25] Tsou Y H, Zhang X Q, Zhu H, et al. Drug delivery to the brain across the blood-brain barrier using nanomaterials [J]. Small, 2017, 13(43): 1701921.